|
|
||||||||
1 Animal Health Discovery Research, The Upjohn Company, Kalamazoo, MI 49002
2 Hill Farm Research Station, Louisiana State University Agricultural Center, Homer 71040
3 School of Veterinary Medicine, Veterinary Medicine Teaching and Research Center, Tulare, CA 93724
4 Department of Animal Science, University of Vermont, Burlington 05403
5 Washington State University, Department of Veterinary Clinical, Medicine and Surgery, Pullman 99164-6610
Minimum inhibitory concentrations were determined with 1494 microorganisms isolated from the mammary glands of dairy heifers. The antimicrobial agents tested were penicillin, cloxacillin, cephapirin, ceftiofur, novobiocin, enrofloxacin, erythromycin, and pirlimycin. All minimum inhibitory concentrations were expressed as micrograms per milliliter. The isolates tested included 135 Staphylococcus aureus, 1222 Staphylococcus sp., 42 Streptococcus sp., 15 Enterococcus sp., 60 enteric species, and 20 miscellaneous organisms. The minimum inhibitory concentrations for 90% of isolates for the various antimicrobial agents with Staph. aureus were as follows: penicillin, .13; cloxacillin, .5; cephapirin, .5; ceftiofur, 1; novobiocin, .5; enrofloxacin, .5; erythromycin, .5, and pirlimycin, .5. In comparison, the minimum inhibitory concentrations for 90% of isolates for the Staphylococcus sp. were 1, 1, .5, 1, .5, .5, 1, and .5 for penicillin, cloxacillin, cephapirin, ceftiofur, novobiocin, enrofloxacin, erythromycin, and pirlimycin, respectively. The minimum inhibitory concentrations for 90% of isolates for the Streptococcus sp. were 2, 32, 2, 2, 8, 1, 64, and 32 for the respective antimicrobial agents; the minimum inhibitory concentrations for 90% of isolates were 4, 64, 32, 64, 4, 1, 4, and 4 for the enterococci. Against the Gram-negative enteric bacilli, only ceftiofur and enrofloxacin were active; minimum inhibitory concentrations for 90% of isolates were 1 µg/ml for ceftiofur and .25 µg/ml for enrofloxacin. Results indicated that the majority of staphylococcal strains were susceptible to the antimicrobial agents tested but that antimicrobial susceptibility varied for Streptococcus sp. Compounds currently available in intramammary infusion products demonstrated poor activity against the enteric organisms.
Key Words: heifer mastitis minimum inhibitory concentration
Submitted on July 13, 1994
Accepted on January 20, 1995
This article has been cited by other articles:
![]() |
S. F. Nunes, R. Bexiga, L. M. Cavaco, and C. L. Vilela Technical Note: Antimicrobial Susceptibility of Portuguese Isolates of Staphylococcus aureus and Staphylococcus epidermidis in Subclinical Bovine Mastitis J Dairy Sci, July 1, 2007; 90(7): 3242 - 3246. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-A. Tenhagen, G. Koster, J. Wallmann, and W. Heuwieser Prevalence of mastitis pathogens and their resistance against antimicrobial agents in dairy cows in Brandenburg, Germany. J Dairy Sci, July 1, 2006; 89(7): 2542 - 2551. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Borm, L. K. Fox, K. E. Leslie, J. S. Hogan, S. M. Andrew, K. M. Moyes, S. P. Oliver, Y. H. Schukken, D. D. Hancock, C. T. Gaskins, et al. Effects of prepartum intramammary antibiotic therapy on udder health, milk production, and reproductive performance in dairy heifers. J Dairy Sci, June 1, 2006; 89(6): 2090 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wenz, F. B. Garry, J. E. Lombard, R. Elia, D. Prentice, and R. P. Dinsmore Short Communication: Efficacy of Parenteral Ceftiofur for Treatment of Systemically Mild Clinical Mastitis in Dairy Cattle J Dairy Sci, October 1, 2005; 88(10): 3496 - 3499. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pitkala, M. Haveri, S. Pyorala, V. Myllys, and T. Honkanen-Buzalski Bovine Mastitis in Finland 2001--Prevalence, Distribution of Bacteria, and Antimicrobial Resistance J Dairy Sci, August 1, 2004; 87(8): 2433 - 2441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schneider, M. Valle, F. Woehrle, and B. Boisrame Pharmacokinetics of Marbofloxacin in Lactating Cows After Repeated Intramuscular Administrations and Pharmacodynamics Against Mastitis Isolated Strains J Dairy Sci, January 1, 2004; 87(1): 202 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gentilini, G. Denamiel, A. Betancor, M. Rebuelto, M. R. Fermepin, and R. A. De Torres Antimicrobial Susceptibility of Coagulase-Negative Staphylococci Isolated from Bovine Mastitis in Argentina J Dairy Sci, August 1, 2002; 85(8): 1913 - 1917. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |